A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 113-118

  Nahm, Moon H ^a   Siber, George R ^b   Olander, Jitka V ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OTITIS MEDIA; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0030064929     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.113     Document Type: Article

References (15)

1. Fedson DS. Pneumococcal vaccine. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. Philadelphia: WB Saunders, 1988:271-99.
2. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
3. Briles DE, Scott G, Gray B, et al. Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J Infect Dis 1987;155:1307-14.
4. Nordenstam G, Andersson B, Bengtsson C, et al. Age-related change in anti-carbohydrate antibody levels. Am J Epidemiol 1989;129:89-96.
5. Briles DE, Claflin JL, Schroer K, Forman C. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature 1981;294:88-90.
6. Nielsen SV, Sørensen UBS, Henrichsen J. Antibodies against pneumococcal C-polysaccharide are not protective. Microb Pathog 1993;14: 299-305.
7. Szu SC, Schneerson R, Robbins JB. Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci. Infect Immun 1986; 54:448-55.
8. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG Responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990;161:728-35.
9. Koskela M, Leinonen M. Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine. J Clin Pathol 1981; 34:93-8.
10. Schiffman G, Douglas RM, Bonner MJ, Robbins M, Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods 1980;33:133-44.
11. Sorensen UBS, Henrichsen J, Chen HC, Szu SC. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb Pathog 1990;8:325-34.
12. Schiffman G, Bornstein DL, Austrian R. Capsulation of pneumococcus with soluble cell wall-like polysaccharide. II. Nonidentity of cell wall and soluble cell wall-like polysaccharides derived from the same and from different pneumococcal strains. J Exp Med 1971;134:600-17.
13. Briles DE, Nahm M, Schroer K, et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 1981;153: 694-705.
14. Chung GH, Scott MG, Kim KH, et al. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. V. In vivo expression of individual antibody clones is dependent on immunoglobulin CH haplotype and the categories of antigen. J Immunol 1993;151:4352-61.
15. Siber GR, Priehs C, Madore DV. Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J 1989;8:S84-91.